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INTRODUCTION. 
The advance in the knowledge of the chemical nature of the carbo- 
hydrate substance (1-3) of Pneumococcus makes it desirable to obtain 
further  evidence of its  biological significance.  Facts  of interest  in 
this connection have been furnished by the reports (4) of the changes 
in immunological properties exhibited by pneumococci which have 
lost the specialized cellular function of elaborating the soluble specific 
substance  (carbohydrate).  Reimann's  (5)  recent paper  adds  value 
to the earlier work (4), since his results indicate that the immunologi- 
cal differences accompanying the loss of the S-producing function can 
be explained upon the basis of Avery and Heidelberger's interpreta- 
tion of the immunological relations of pneumococcus cell constituents. 
It is the object of the present paper to present evidence of similar 
nature, but with special emphasis upon the immunological reactions 
involved in the protection of mice against virulent Type II pneumo- 
cocci.  The  study  consisted of  a  comparison of  the immunological 
properties  of  two  strains  of pneumococci: a  type-specific strain  in 
which the S-producing function of the cell was highly developed; and 
a  non-type-specific  strain  in  which  the  S-producing  function  was 
completely lost.  The comparison of the two strains from the stand- 
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point of  antipneumococcus  protection  of  mice  was  investigated  by 
active  and  passive  immunity  tests,  and  by  the  absorption  of  anti- 
pneumococcus  serum  with  whole  bacterial  cells  and  with  culture 
filtrates. 
EXPERIMENTAL. 
Strains  of  PneumococcL--Two  strains  of pneumococci were employed in the 
investigation: (I) an  S-producing  I (Type II)  strain;  (2) a  non-S-producing  I 
strain  derived by the "spontaneous degradation" of the first  strain. S-Produclng 
Strdin.--Strain  D89, Type II (Hospital  of The Rockefeller  Institute)  was used as 
the S-producing or type-specific  strain.  It was highly  virulent,  its  lethal  dose for 
mice never being greater than  one-millionth  cc.  of culture.  Non-S-Producing 
Strain.--The non-S-producing or non-type-specific strain was derived from the 
above type-specific strain by repeated transfers in broth made at infrequent in- 
tervals.  The culture finally used had passed through 50 successive  transfers in 
broth at intervals of 2 to 3 days; it had completely lost its S-producing function, 
and was no longer pathogenic for mice. 
Serological Reactions  of the S-Producing  and Non-S-Producing  Strains 
of Pneumococci. 
In type-specific antipneumococcus serum, the  S-producing  strain exhibited the 
usual serological reactions; the bacteria themselves were agglutinated and the car- 
bohydrate or S substance in culture filtrates was precipitated.  In contrast, the 
bacterial cells of the non-S-producing strain were not agglutinated, nor were the 
supernatants of its broth cultures precipitated.  The results obtained in species- 
specific antipneumococcus protein serum were quite different.  The S-producing 
strain was not specifically agglutinated, nor was the carbohydrate substance in its 
filtrates precipitated.  The non-S-producing strain, on the other hand, was agglu- 
tinated by the serum which contained the species-specific antiprotein antibodies. 
The differences between the serological reactions of the S-producing  and non-S- 
producing strains are essentially the same as those which have been reported by 
Reimann.  The differences  in agglutinabllity can be explained upon the basis of 
Avery and Heidelberger's schematic interpretation of the structure of the pneu- 
mococcus cell.  The type-specific agglutination of the S-producing strain may be 
x The term "S-producing" strain as employed throughout this paper refers to 
the original,  virulent, highly type-specific strain which  possesses  the specialized 
cellular function of elaborating the immunologically reactive carbohydrate sub- 
stance.  The same properties are exhibited by Reimann's "S" strains. 
The term "non-S-producing" strain refers to the avirulent,  non-type-specific 
strain which has lost the property of producing the soluble  carbohydrate.  Its 
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referred to the reaction between the ectoplasmic layer of specific carbohydrate 
and the type-specific anticarbohydrate antibodies; the species-specific agglutina- 
tion of the non-S-producing  strain may be referred to the reaction between the 
protein on the outside layer of the degraded bacterial cell and the species-specific 
antiprotein antibodies. 
Antigenic Properties of the S-Producing and Non-S-Producing Strains 
of PneumococcL 
The differences in the antibody-invoking properties of the S-producing and non- 
S-producing  strains were investigated by immunizing  two series of rabbits with 
heated suspensions of the two sorts of pneumococci.  The production of test-tube 
demonstrable antibodies was essentially the same as that reported by Reimann (5). 
The S-producing  strain invoked the production of anticarbohydrate antibodies 
(type-specific agglutinins  and type-specific  S precipitins).  The non-S-producing 
strain, on the other hand, was entirely devoid of the capacity to invoke the anti- 
carbohydrate antibodies,  and  the  serum obtained contained only the species- 
specific antiprotein antibodies and none of the type-specific antibodies. 
The  differences in  the  protective value  of  the  serum  yielded  by 
immunization  with  the  two  strains  are  of more  importance  in  the 
present paper than  are  the above serological reactions.  The serum 
of animals immunized with the S-producing strain had a high passive 
protective value, regularly protecting mice against 0.01 cc. of virulent 
Type  II  pneumococci.  In  contrast,  the  serum  of  all  animals  im- 
munized with the non-S-producing strain was entirely devoid of any 
protective power, although it possessed a high titre of species-specific 
antiprotein antibodies.  Apparently, when the Type II pneumococcus 
cell loses its S-producing function, it no !onger possesses the antigenic 
complex which  invokes  the production of passively protecting anti- 
bodies. 
Active Immunization  of Mice with S-Producing and Non-S-Producing 
Pneumococci. 
Since there are frequent differences between passive and active antibacterial 
immunity (8), the following experiments were made to determine whether or not 
active immunity could be established by the vaccination of mice  with non-S- 
producing pneumococci. 
One series of ten mice was immunized with heat-killed vaccine prepared from 
the type-specific or S-producing strain, and another series with vaccine from the 
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tions were given with a  rest period of 1 week between courses; each course con- 
sisted of five doses of vaccine, each dose being given at 2 day intervals, equivalent 
to 0.15 cc. of broth culture.  Tests for active immunity were made 11 days after 
the last vaccination, by the intraperitoneal injection of different amounts of Type 
II pneumococcus culture (10 -6 to 10 4  cc.).  Normal mice (not vaccinated) were 
injected with 10 -6 cc. as virulence controls of the culture. 
The results of the active immunity tests revealed the same differ- 
ences in the antigenic properties of the two strains as those previously 
observed  in  the  passive  protection  experiments.  Although  the 
protection was not uniform, some of the mice which had been actively 
immunized with  the  S-producing pneumococci survived  the  injec- 
tion of doses of virulent Type II organisms equivalent to as much as 
one-thousandth cc. of culture.  2  In contrast to the series immunized 
with the type-specific organisms, none of the animals which had been 
vaccinated with  the  non-S-producing strain  had  acquired  any  de- 
tectable immunity and all were infected by doses of one-millionth cc. 
of the virulent culture.  Apparently, therefore, the loss of the S-pro- 
ducing function of Type II pneumococci was accompanied by loss of 
the capacity to establish active immunity in mice, as well as by loss 
of the capacity to invoke passively protecting antibodies. 
Absorption  of  Type  II  Antipneumococcus Serum  with  S-Producing 
and Non-S-Producing  Pneumococcu¢ Cells. 
The results of preceding experiments have shown distinct differences 
in  the antibody-invoking properties of the S-producing and non-S- 
producing pneumococci: the serum of animals immunized with  the 
S-producing strain contained type-specific antibodies (agglutinins and 
S precipitins) and passively protected mice against Type II pneumococ- 
cus infection; in contrast, the serum of animals immunized with the 
non-S-producing strain contained no demonstrable type-specific anti- 
The irregularity in the protection of the mice in this series of vaccinated mice 
had no relation to the dose of pneumococci injected in the active immunity tests. 
Some individuals injected with 10 -ecc. and 10 -~ cc. were infected, while others 
injected with 10 -4 cc. and 10 -z cc. Were protected.  As reported in the following 
paper, the results of an investigation with a  larger series of mice show that the 
above irregularities were due to differences in the immunity response of the individ- 
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bodies and did not protect mice.  In view of these marked differences 
in  the  antibody-invoking properties  of  the  two  strains,  experiments 
were made  to determine if like differences existed  in  the  capacity of 
the  two  strains  to  "absorb" or  remove antibodies  from type-specific 
immune serum. 
A  type-specific serum obtained by immunization of a  rabbit with  Type II 
pneumococcus vaccine was used in the absorption experiment.  This serum con- 
tained the usual type-specific agglutinins, S precipitins, and passively protecting 
antibodies. 
10 cc. of serum were placed in each of three tubes.  10 cc. of a salt solution 
suspension of heat-killed bacteria of the S-producing strain were added to one tube 
of serum; the same amount of a suspension of the non-S-producing pneumococci 
TABLE  I. 
Absorption of Type II Antipneumococcus Serum witk S-Producing and Non-S- 
Producing Pneumococci. 
Type-speclfic  antlpneumococcus  serum  Type II  Precipitins for  Passively  agglutinins  Type n  soluble  protecting 
substance  antibodies 
Unabsorbed ..............................  +  +  + 
Absorbed  with  S-producing  Type  II  pneu- 
mococci  ................................  0  0  0 
Absorbed with non-S-producing  pneumococci.  +  +  + 
was added to the second tube of serum; an equal volume of salt solution was added 
to the third tube.  The three mixtures were shaken for 5 minutes, then incubated 
for 2 hours at 37°C., and finally placed in the ice box for 12 hours.  The tubes 
were then centrifuged to remove the bacteria.  10 cc. of the supernatant fluid 
from the above mixtures were then placed in each of three tubes and absorbed a 
second time by the same procedure. 
After the removal of the bacteria used in the second absorption, the three sera 
((1) unabsorbed control, (2) absorbed with S-producing pneumococci, (3) absorbed 
with non-S-producing pneumococci) were then tested for the presence of type- 
specific  agglutinins, type-specific S precipitins, and type-specific protective anti- 
bodies.  The agglutination and protection tests were made by the usual procedure. 
In the S precipidn tests, the bacteria-free filtrate of a young unautolyzed culture 
of Type II pneumococci was substituted for a solution of the purified carbohydrate. 
The results of the experiment are summarized in Table I. 
The results of the absorption experiments (Table I) reveal the same 
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immunization  experiments.  Absorption  with  the  heat-killed  cells 
of the  S-producing  strain  removes all the  S  precipitins,  type-specific 
agglutinins,  and  protective  antibodies,  just  as  immunization  with 
the bacterial cells of this strain invokes the production of these same 
type-specific:  antibodies.  On  the  other  hand,  absorption  with  cells 
of the strain in which  the S-producing function has been lost fails  to 
remove any of  these  antibodies,  just  as  immunization  with  cells  of 
this  strain  failed  to  stimulate  the  production  of  type-specific  anti- 
bodies.  Hence,  the  pneumococcus  cells  which  have  lost  their  S- 
producing function have lost not only their property of invoking type- 
specific antibodies by antigenic  stimulation  in  the animal body,  but 
have also lost their capacity to "absorb" the same antibodies by type- 
specific antigen-antibody combinations in the  test-tube. 
A bsorption of Type II A ntipneumococcus Serum with Culture Filtrates 
of S-Producing  and Non-S-Producing  Pneumococci. 
In the following experiment, Type II antipneumococcus serum was absorbed 
with filtrates of young broth cultures of the S-producing and non-S-producing 
pneumococci.  It seemed that the results to be obtained by absorption of the 
serum with the filtrates should be comparable to those obtained by use of solu- 
tions of the chemically purified carbohydrate since  the S substance is the only 
immunologically reactive substance  which  can be demonstrated in  filtrates of 
young and unautolyzed broth  cultures  of Pneumococcus.  (The S substance is 
liberated into the culture fluid in the early period of growth and if the fluids are 
filtered before cell disintegration has commenced, the filtrates are entirely free of 
any of the bacterial protein or other serologically  reactive substances.)  To ob- 
tain fluids containing the maximum amount of the soluble substance, the cultures 
were planted in glucose broth.  The reaction of the cultures was observed closely 
and when a pH of approximately 6.5 was reached, the bacteria were removed by 
centrifugation, the reaction adjusted to pH 7.3, and the fluids filtered through a 
Berkefeld candle. 
5 cc. of the antipneumococcus (Type II) serum were then placed in each of three 
tubes.  15 cc. of the filtrate from the S-producing  culture were added to the first 
tube; 15 cc. of the filtrate from the  non-S-producing  culture were added to the 
second tube; an equal volume of broth was added  to the third tube as a control. 
All the mixtures were shaken for 15 minutes, incubated for 3 hours at 37°C., and 
then placed in the ice box for 18 hours.  The mixtures were then centrifuged and 
the clear supernatant fluids removed.  A second absorption similar to the above 
was carried out with 10 cc. of the supernatant fluid of each of the above serum mix- 
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added to the serum which had received the preceding absorption treatment with 
this filtrate.  After 3 hours at 37°C. and 18 hours at 5°C., the second series of 
mixtures was centrifuged and the supernatant fluids again removed.  The super- 
natant fluids were then subjected to a third absorption by the described procedure. 
The mixtures were again centrifuged and the supernatant fluids removed.  The 
supernatant fluids of  the third absorption series were employed in the following 
tests.  The sera at this stage had been diluted to about one-twenty-fifth of their 
volume, so that each cc. of the test sera contained approximately 0.04 cc. of serum 
and 0.96 cc. of broth, or culture filtrate. 
Tests for type-specific agglutinins were made by the usual method with dilu- 
tions equivalent to 1/25 and 1/100 of the original serum.  Two series of passive 
protection tests were made with different amounts of serum.  One series of mice 
TABLE  II. 
Absorption of  Type  II  Antipneumococcus Serum with Culture Filtrates of 
S-Producing and Non-S-Producing Pneumococci. 
Type II antipneumococcus serum 
"Unabsorbed control ........... 
Absorbed  with culture  filtrate 
of S-producing pneumococci.. 
Absorbed with culture filtrate 
of  non-S-producing  pneu- 
mococci  ................... 
Passive  protection 
Mice injected with Type II pneumococci 
Amount of culture 
I0  cc.  I  I0-~  cc.  10  -6  cc. 
[  s  s 
D  D 
10-6 cc. 
Type-specific 
agglutmins 
Serum dilutions 
1/25 
+ 
0 
+ 
1/xoo 
+ 
0 
+ 
S  =  survived 7 days.  D  =  died 24 to 48 hours after injection. 
received absorbed serum equivalent to 0.04 cc. of the original serum mixed with 
increments of broth culture ranging from l0 -~ cc. to 10 -e cc.  A second series of 
mice received the equivalent of 0.01  cc. of serum mixed with amounts of broth 
culture ranging from 10 -3 cc.  to 10 -8 cc.  The second series of protection tests 
was included to detect any incomplete absorption of protective antibodies which 
might not be recognized in tests with an excess of serum.  Since the tests with the 
two amounts of serum gave identical results, only the results of the series with 
0.04 cc. of serum are included in the summarized protocol presented in Table II. 
Since the S substance was used for the absorption in the form of a solution in 
the filtrate of the S-producing strain, a slight excess of the carbohydrate remained 
in the serum mixture after the final absorption.  Thus, it is obvious that a certain 
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tests with absorbed serum.  In the absence of any evidence of an "aggressin"- 
like effect of small amounts of the S substance, we do not believe that this compli- 
cated the results of the experiment. 
This experiment (Table II) shows that absorption with the filtrate 
of  the S-producing strain  removed all  the  type-specific agglutinins 
and also all the protective antibodies,  a while the filtrate of the non-S- 
producing strain failed  entirely to  remove any of the  type-specific 
antibodies and did not diminish the protective value of  the serum. 
These results of the absorption with the culture filtrates were exactly 
analogous to the results (Table I) of the absorption with the heated 
whole cells of the two  strains of pneumococci and,  because of the 
simpler nature of the culture filtrates, furnish more direct evidence of 
the relation of Type II anti-S antibodies to protection. 
The above results are also of interest from the standpoint of the 
identity  of  the  type-specific  agglutinin and  the  anti-S  precipitin. 
Avery  and  Heidelberger's  (3)  contention  that  S  precipitation and 
type-specific agglutination involve the same antigen-antibody com- 
bination, is supported by the fact that S precipitins are removed by 
absorption with suspensions of washed pneumococcus cells (Table I) 
and  conversely by  the  fact  that  the  type-specific  agglutinins  are 
removed by absorption with solutions of  the S substance (Table II). 
The studies of the soluble substance of Pneumococcus by Avery 
and Heidelberger (2, 3)  and of the similar products of other bacteria 
by Zinsser and Mueller (9)  have presented new conceptions of the 
importance of  carbohydrates  in  immunology.  From  this  point of 
view, the results in Table II are of general interest as an example of 
the removal of the protective antibodies of an  antibacterial  serum 
by absorption with solutions in which the only reactive substance is 
carbohydrate in nature. 
DISCUSSION. 
The elaboration of the soluble specific substance (carbohydrate) is 
a  specialized function of the pneumococcus cell which is most highly 
s It is important to note that this complete removal of protective antibodies by 
absorption with the S-conta'ming fluid occurred in Type H  immune rabbit serum. 
In similar  experiments  with  Type I  serum  from an immune horse,  protective 
antibodies were not completely absorbed when treated with culture fluid contain- 
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developed in virulent strains.  The loss of the function of S produc- 
tion is accompanied by changes in the immunological properties  of 
pneumococci.  As  previously pointed  out  by Reimann  (5),  strains 
of pneumococci which no longer elaborate the specific carbohydrate, 
lose  their  type-specific  serological properties  and  exhibit  antigenic 
properties similar to those of solutions of pneumococcus protein (6, 
7).  In addition to the immunological changes mahifested by differ- 
ences in  test-tube serological reactions,  the loss of the S-producing 
function was also  accompanied by marked  changes in the antigenic 
properties  involved in both  passive  and  active protection of mice. 
The injection of S-producing pneumococci stimulated the production 
of passively protecting antibodies in rabbits and also established active 
immunity in mice.  On the other hand, the similar injection of non-S- 
producing pneumococci neither invoked the production of passively 
protecting antibodies nor established active immunity. 
The intimate relation of the type-specific antibodies  to  the anti- 
pneumococcus protection of mice was likewise evident in the results 
of absorption experiments.  Absorption of Type II antipneumococcus 
serum with the heat-killed cells of S-producing pneumococci of homol- 
ogous type removed the commonly recognized antibodies  concerned 
in  type-specific  agglutination  and  in  type-specific precipitation  of 
solutions of the S substance.  Serum from which these type-specific 
antibodies had  been  removed were completely devoid of passively 
protecting antibodies.  On the other hand, when the Type II serum 
was subjected to the same absorption treatment with non-S-producing 
pneumococci, there was no detectable loss in the  type-specific anti- 
bodies  responsible  for  agglutination  and  S  precipitation.  This 
absorbed serum from which the type-specific antibodies had not been 
removed, possessed the same protective value as unabsorbed serum. 
More direct evidence of the relationship between the anticarbohydrate 
and the protective antibodies was furnished by the fact that absorp- 
tion of Type II antipneumococcus serum with culture filtrates con- 
mining the S substance in solution removed the protective antibodies 
as completely as did the whole bacteria themselves.  It is reasonable 
to believe that the removal of the protective antibodies was due to 
the reaction between the carbohydrate S substance and its type-specific 
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Although antipneumococcus immunity is  type-specific and conse- 
quently the antibodies that confer it must also be type-specific, it is 
hazardous to conclude that Type II antipneumococcus protection is 
simply a function of the anticarbohydrate antibody.  A  number of 
reports have been made of the protective value of antipneumococcus 
serum  which  possesses  none  of  the  usual  test-tube  demonstrable 
antibodies.  However, all our results indicate that the type-specific 
anticarbohydrate antibody is at least the dominant one involved in 
the protection of mice against virulent Type II pneumococci. 
It is common experience (10) to find that the production of effective 
antipneumococcus serum requires the use of virulent pneumococci in 
the immunization.  If the anti-S antibody is the one most prominently 
involved in Type II passive protection, the failure to obtain an effec- 
tively protecting serum by immunization with avirulent pneumococci 
would be explained not by the loss of the virulence of the bacteria 
employed as antigens, but by the fact that the avirulent bacteria no 
longer possess the antigenic complex (SP of Avery and Heidelberger 
(3))  which  is  required for  the  immunological production  of  type- 
specific antibodies. 
SUMMARY. 
The loss of the specialized function of S production by Type II 
pneumococcus was accompanied by a loss of the antigenic properties 
involved in both active and passive protection of mice.  Absorption 
of  Type II  serum with  S-producing pneumococci removed all  the 
protective antibodies, as well as the type-specific agglutinins and S 
precipitins.  The same absorption treatment of the serum by non-S- 
producing pneumococci failed  entirely  to  remove  the  type-specific 
antibodies and did not affect the protective value of the serum.  Ab- 
sorption  with  bacteria-free  culture  fluids  containing  the  reactive 
carbohydrate  removed  the  protective  antibodies  as  completely as 
absorption with the whole bacterial cells of type-specific strains.  The 
results taken as a whole indicate that the antibodies involved in the 
usual  protection of mice against  Type II  pneumococci are  closely 
related, if not identical, to the specific anticarbohydrate precipitin. E.  L.  GASPARI, W.  L.  FLEMING, AND  J.  M.  NEILL  111 
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